Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Stem-Cell-Mobilization in Subjects With Diabetic Neuropathy Receiving SB-509

NCT00665145 is registered in ClinicalTrials.gov with Sangamo Therapeutics as lead sponsor.

NCT NCT00665145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00665145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Stem-Cell-Mobilization in Subjects With Diabetic Neuropathy Receiving SB-509
Lead sponsor
Sangamo Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
October 31, 2009
Enrollment
23 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1, diabetes mellitus, type 2, diabetic polyneuropathy